Advertisement

Topics

Codexis to Present at Two Investment Conferences in November

19:00 EST 8 Nov 2017 | Globe Newswire

REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at two investment conferences in November:

  • 8th Annual Craig-Hallum Alpha Select Conference on Thursday, November 16, 2017 at 9:20 a.m. Eastern time (6:20 a.m. Pacific time). The conference is being held at the Sheraton Times Square Hotel in New York City.
  • Furey Research Hidden Gems Conference on Thursday, November 16, 2017 at 2:45 p.m. Eastern time (11:45 a.m. Pacific time). The conference is being held at the University Club of New York in New York City.

A live webcast and replay of the presentation at the Craig-Hallum Alpha Select Conference will be available on the Investors section of the company’s website, http://ir.codexis.com/.

About Codexis, Inc.

Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals, as well as the development of enzymes as biotherapeutics and for molecular diagnostics. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.

Contacts: 

Investors
LHA Investor Relations
Jody Cain, 310 691 7100
jcain@lhai.com

NEXT ARTICLE

More From BioPortfolio on "Codexis to Present at Two Investment Conferences in November"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...